Upfront combination therapy with nintedanib and anti-inflammatory agents for progressive pulmonary fibrosis: a multicentre, single-arm phase 2 study (TOP-ILD)
尼达尼布联合抗炎药一线治疗进行性肺纤维化:一项多中心、单臂 2 期研究 (TOP-ILD)
期刊:Erj Open Research
影响因子:4
doi:10.1183/23120541.00697-2025
Tsubouchi, Kazuya; Hirose, Masayuki; Takei, Reoto; Fujisawa, Tomoyuki; Tobino, Kazunori; Ichiyasu, Hidenori; Izumi, Shinyu; Sakamoto, Noriho; Asami-Noyama, Maki; Nishiyama, Osamu; Waseda, Yuko; Nakanishi, Masanori; Baba, Tomohisa; Chiba, Hirofumi; Furusawa, Haruhiko; Zaizen, Yoshiaki; Ishii, Hiroshi; Okamoto, Masaki; Kondoh, Yasuhiro; Ogura, Takashi; Ichikado, Kazuya; Okamoto, Isamu